Introduction: The purpose of this study was to induce hyperprolactinemia in adult male rats and determine its effect on the central and peripheral mediated neurogenic as well as myogenic mechanisms of erectile functionadysfunction in a rat model. The use of penile re¯exes in awake animals was used to test the effect of both central and peripheral mechanisms. Electrical stimulation of the cavernous nervous was used to test peripheral neural function and intracorporal injection of papaverine was used to test the intactness of the corporal smooth muscles. These mechanisms were further explored by administration of testosterone. Methods: Eighteen Fisher-344 200 ± 250 g rats aged 10 weeks were used in this study. Group 1 (n 6) hyperprolactinemia was induced with subcutaneous (SQ) injection of 5 mg rat prolactin (NIDDK-r-PRL-B-7, biopotency 25 IUamg) in two divided doses daily for 1 week. Testosterone propionate 100 mgakg dissolved in sesame oil was given intramuscularly on day 1 (weekly dose). Group 2 (n 6) control animals received SQ injection of vehicle twice daily and sesame oil IaM on day 1. Group 3 (n 6) received testosterone propionate. Penile re¯exes (erections, cups,¯ips and clusters) were assessed prior to induction (63) of and following one-week state of hyperprolactinemia (day 5, 6 and 7). All animals were trained three times before recording the penile re¯exes. The penile re¯exes being averaged to give a single composite score for each animal. All animals underwent dissections that isolated the cavernosal bodies and cavernosal nerves. Cavernous nerves were activated and intracorporal pressures were recorded at increasing current magnitude (range 0.5 ± 10 mA). Following that corporal smooth muscle reactivity was determined by increasing injection of papaverine (100 ± 3000 mg). Concentration response curves (CRCs) were then generated by plotting percent change (fractional change to make standardized comparison) to increasing neurostimulation or papaverine concentrations at half-log increments. Serum prolactin was determined by rPRL radioimmunoassay Kit-Amersham while serum testosterone was determined Testosterone ELISA Kit-Neogen. Results: Penile re¯exes were normal in all groups at the start of experiment but after 1 week of hyperprolactinemia, re¯exes were totally abolished in hyperprolactinemia rats (Group 1) and unchanged in Groups 2 and 3. Response to cavernous nerve activation and resulting rise in intracorporal pressure to increasing current (range 0.5 ± 10 mA) were statistically non-signi®cant in any groups. Similarly the intracorporal pressure response to pharmacologic erection induced by papaverine (100 ± 3000 mg) were also non-statistically signi®cant in any groups. Serum prolactin level in all rats receiving prolactin were b 500 ngaml and the rat group receiving testosterone, serum level were b 206higher than the control rat. Conclusions: This approach allowed more clear separation of central and peripheral mechanism of erection. This study shows a central neurological effect of hyperprolactinemia on erectile function. Hypogonadism does not seem to contribute to the impaired penile re¯exes as documented by replacement of testosterone did not recover the centrally mediated penile re¯exes. Lowered serum testosterone is secondary phenomenon. These observations may have important implications for the understanding, the mechanism and treatment of men with hyperprolactinemia as well as future research in this ®eld.
Introduction
Hyperprolactinemia is known to suppress erectile and reproductive function in human and rodent males 1 but the mechanism of its effect on penile erection is unknown. 2, 3 The clinical presentation of a man with hyperprolactinemia is both diminished libido and inability to either obtain or maintain a rigid erection. Although plasma testosterone levels are usually reduced in the hyperprolactinemic state correction of the low testosteronemia with administration of intramuscular testosterone does not correct the erectile abnormality. Recovery of potency with bromocriptine treatment occurs before gonadal function normalizes. 4 Hyperprolactinemia stimulates dopamine and oxytocin release that may have a role in orgasm. However, it is also known that hyperprolactinemia markedly increased dopamine synthesis, turnover, and release, from neurons of the hypothalamus. 5 Hyperprolactinemia also caused marked increases in the expression of tyrosine hydroxylase mRNA in the hypothalamic arcuate and periventricular nuclei and the zona incerta. 6 The hypothalamus is the region of the brain associated with sexual and erectile function. 7 Mild elevation of prolactin are thought to be stress related and thus may provide a lead to understanding the neurobiological correlates of psychogenic impotence. Aoki and associates 8 have reported that acute infusion of prolactin into the corporal bodies of dogs inhibited relaxation of corporal smooth muscle subsequently subjected to electrical pulse stimulation of the pelvic nerves. They suggested a direct effect on the smooth muscle function of the cavernous bodies by prolactin.
The purpose of this study was to induce hyperprolactinemia in adult male rats by injection of exogenous hormone to identify whether central or peripheral mechanism was responsible for the effects of erectile dysfunction. The use of penile re¯exes 9 ± 11 in awake animals was used to test the effect of both central and peripheral mechanisms. Electrical stimulation of the cavernous nervous 12 ± 14 was used to test peripheral neural and cavernous nerve function and intracorporal injection of papaverine 14 used to test the intactness of the corporal smooth muscles.
Materials and methods

Animal preparation and pretreatment
Eighteen male`Fischer 344' rats (F-344, Taconic Farms, Germantown, NY) 8 ± 10 weeks old, and weighing 200 ± 250 g were used in these experiments. The rats were housed under 14 h lighta10 h dark schedule (lights on 05:00 to 19:00 h). The animals were housed in groups of 2 ± 3 in clear plastic cages in a temperature controlled room (23 AE 1 C). All rats were fed Purina lab rodent chow ad libitum and housed individually.
Experimental design and treatments
Group 1 (n 6). Hyperprolactinemia was induced with SaQ injection of 5 mg rat prolactin (NIDDK-r-PRL-B-7, biopotency 25 IUamg) in two divided doses daily for 1 week as well as testosterone propionate 100 mgakg dissolved in sesame oil (Sigma, St. Louis, MO) intramuscular on day 1. The r-PRL-B-7 prepared in 50% polyvinyl pyrrolidone (PVP): 50% 0.01 M NaHCO 3 buffer (pH 8.6, 25 C) depot. PVP dissolved in water or NaHCO 3 buffer is acidic, hence the net pH was adjusted to 8.6 with base (5.0 M NaOH). The r-PRL-B-7 (biopotency 25 IUamg) was injected subcutaneously every 12 h (two divided doses) in a 50% polyvinyl pyrrolidone (PVP): 50% 0.01 M NaHCO 3 buffer (pH 8.6, 25 C).
Group 2 (n 6). Control animals received SQ injection of PVP vehicle 0.3 ml twice daily and 0.25 ml of sesame oil intramuscular once on day 1.
Group 3 (n 6). Received testosterone propionate 100 mgakg dissolved in sesame oil (Sigma) intramuscular once on day 1.
Evaluation of penile re¯exes (centrally induced erection). Penile re¯ex responses in hyperprolac-
tinemia and control groups were elicited by retraction of the penile sheath. Sacks and Garinello 9 described three major groups of responses in sexually mature rats; namely erections, cups, and ips. Erections, as in humans, 9, 11 were characterized by the engorgement of the penis with blood and by the accompanying extension and rigidity. Cupping: intense erections that result in a¯aring of the head of the penis into a cup-like con®guration`cup' are associated with the placement of the ejaculatory plug against the cervix. A tight ®tting plug ensures adequate sperm transport and inhibits plug displacement by another male. 15 A¯ip was a sharp involuntary dorsi¯exion of the penis towards the abdomen with rapid return to resting. Penile¯ip appears to be related to the function of the ischiocavernous muscle and plays a role in the animal ability to intromit. 16 ± 18 Dorsi¯exion of the glans penis`¯ips' is associated with gaining a proper orientation for penile insertion during copulatory mounts. A group that consisted of each type of re¯ex occurring in series was named a cluster. Thus responses observed in the supine penile re¯ex test correlated to penile responses.
Rats displaying good penile re¯exes (greater than 10a20 min) were included in study after initial screening. In order to measure rat penile re¯exes, non-anaesthetized animals were placed into plastic cups ®xed to a wood backboard for partial restraint. Animals were then¯ipped on their backs and secured with tape. This con®guration provides exposure of the rear legs and genitalia, while preventing escape of the rat. The prenuptial sheath, after being retracted by hand, was held back with the tip of a thin glass pipette for the remaining part of the test, permitting the number of each type of re¯ex to be readily observed. All animals were trained three times before recording the penile re¯exes. (Once per 24 h63). Records were kept of the latency from the time of sheath retraction to observation of the ®rst re¯ex, and furthermore, counts of each type of response were made in each rat over a 15 min interval. Timing intervals were started following observation of the ®rst re¯ex action, or after 20 min, whichever came ®rst. Therefore, animals in which there was a total absence of detectable re¯exes were observed for a maximum of 35 min. If no response at all was observed in 35 min, the rat was released and scored as a zero. Each animal was examined once per night over a 2 ± 3 d period, with the penile re¯exes being averaged to give a single composite score for each animal before and after the experimental period. All experiments were conducted between 20:00 and 04:00 hours. Penile re¯exes were assessed prior to and after induction of hyperprolactinemia (day 5, 6, 7).
Surgical methodology (preparation of rat for cavernous nerve stimulation and intracorporal injection of papaverine) see Figure 1 On day 7 after induction of hyperprolactinemia anesthesia was induced by the intraperitoneal injection (35 mgakg) of sodium pentobarbital (Anpro Pharmaceuticals). Anesthesia was maintained during the course of the experimental protocol (2 ± 3 h) by subsequent injection of pentobarbital (5 ± 10 mgakg) every 45 ± 60 min, as required for maintenance of anesthesia.
Animals were placed in the supine position and the bladder and prostate were exposed through a midline abdominal incision. The inferior hypogastric plexus (i.e. the pelvic plexus or major pelvic ganglia), pelvic nerves and the cavernous nerve were identi®ed posterolateral to the prostate on both sides, and the stainless-steel bipolar wire electrodes were placed around these structures for electrical stimulation. The penis was denuded of skin, both crura (corpus cavernosum) were exposed by removing part of the overlying ischiocavernous muscle. In order to monitor intracorporal pressure (ICP), a 23-gauge cannula was ®lled with 250 Uaml of heparin solution, connected to PE-50 tubing (Intramedic, Becton Dickinson, NJ) and inserted into the right corpus cavernosum (crura). The tubing was then ®xed to the tunica with a 7-0 Dermalon suture, to ensure stability during measurement of ICP. Another 23-gauge cannula was connected to a 1-ml syringe and inserted into left corpus cavernosum for intracorporal drug injection. Systemic arterial blood pressure was monitored via a 25-gauge cannula placed into the carotid artery.
Both pressure lines were connected to a pressure transducer, which was, in turn, connected via a transducer ampli®er (ETH 400 CB Sciences Inc) to a data acquisition board (Mac Laba8e, ADI Instruments, MA). Real-time display and recording of pressure measurements was performed on a Macintosh computer (Mac Lab software V3.4, ADI Instruments, MA). The pressure transducers and AaD board were calibrated in cm of H 2 O before each experiment.
Cavernous nerve neurostimulation (peripheral erection). Electrical stimulation of the cavernous nerve, and the concomitant rise in intracorporal pressure, was chosen as a physiological index of autonomic neuropathy, as the cavernous nerve, which contains adrenergic, cholinergic and nonadrenergic-noncholinergic neurons, represents the ®nal common autonomic pathway to the corporal parenchyma. Direct electrostimulation of the cavernous nerve was performed with a delicate stainlesssteel bipolar hook electrode attached to the multijointed clamp. Each probe was 0.2 mm in diameter; the two poles were separated by 1 mm. Monophasic rectangular pulses were delivered by a signal generator. Stimulation parameters were as follows: frequency, 20 Hz, pulse width; 0.22 ms, duration; 1 min. The current protocol was the application of increasing current 0.5, 1, 2, 4, 6, 8 and 10 mA. Changes in intracorporal pressure recorded were plotted as a fractional change in corporal pressure in relation BP at each level of neurostimulation.
Phamacologic protocol (drug induced erection). After completion of the neurostimulation protocol, a resting period suf®cient to ensure return of basal intracorporal pressure was allowed ( % 15 ± 30 min) prior to beginning the pharmacological experiments. When basal intracorporal pressure was achieved, papaverine (Eli Lilly & Co., Indianapolis, IN) was injected into the left crura (corpus cavernosum) using a 23-G needle attached to a syringe. Four bolus injections of papaverine were administered to each rat at half-log increments ranging from 100 ± 3000 mg (i.e. 100 mg, 300 mg, 1000 mg, 3000 mg). The change in intracorporal pressure was monitored with each dose, and all pressure responses were allowed to return to baseline before injection of the subsequent dose % 15 ± 30 min in most cases. Intracavernous injection of saline alone at volumes of 50 and 100 ml were routinely performed at the beginning of experiment to document that the introduction of¯uid directly into corpus cavernosum per se is not a confounding factor. Changes in intracavernous pressure recorded were plotted as a fractional change in corporal pressure in relation to BP (to standardise) at each dose concentration. Upon completion of experiment Experimental hyperprolactinemia in a rat model J Rehman et al procedures animals were sacri®ced. Blood was collected from aorta and the serum harvested and stored at À20 C for later assay of serum hormone levels.
Prolactin hormone assay (radioimmunoassay, Amersham)
Serum prolactin level was done by radioimmunoassay determined by commercial kit (rPRL radioimmunoassay I 125 Assay system Kit 1 ± Amersham International, UK). Data is expressed in ngaml. The intra-assay coef®cient of variation was 3.2%. Prolactin level in rat receiving r-PRL-B-7 was b 500 ngaml while levels in the control werè 20 ngaml.
Testosterone hormone assay (ELISA, Neogen)
Serum testosterone were by enzyme-linked immunosorbent assay method by commercial kit (Testosterone ELISA Kit 1 ± Neogen, Lexington, KY). Brie¯y, extraction of testosterone from serum of rats. Samples and standards placed on testosterone antibody coated plate and enzyme conjugate, mix and incubate 4 h, wash with buffer (WA2). Bound enzyme conjugate detected by coloring agent (KBlue) in the kit. Absorbance reading compared to standard with spectrophotometer at 650 nm. Plot the standard curve and estimate the concentration of sample from curve.
Statistical data analysis
All statistical analyses were performed using the Stat-View 4.5 software (Abacus Concepts, Berkeley, CA). ANOVA was for comparison of groups. Posthoc tests including scheffe's and Bonferroni. All differences were considered signi®cant at P`0.05. Unless otherwise stated, all data are expressed as the mean SEM.
Results
Penile re¯exes (central erection)
Penile re¯exes were normal in all groups at the start of experiment but after induction of hyperprolactinemia re¯exes (day 5, 6 and 7) were totally abolished in hyperprolactinemic rats (Group 1) and unchanged in Groups 2 and 3. The results of these experiments are summarized in Table 3 and Figure 4 .
Electrical stimulation of the cavernous nerve (peripheral or re¯ex erection)
Electrical stimulation induced erections and resulting rise in intracorporal pressures were not statistically different in all three groups. The results, which are summarized in Table 1 and Figure 2 , demonstrate that, despite the hyperprolactinemic rats' inability to obtain a re¯ex erection, they had normal erectile activity with cavernous nerve stimulation.
Pharmacological response to papaverine (corporal smooth muscle reactivity)
Intracavernous pressure response to pharmacologic erections induced by papaverine (100 ± 3000 mg) were also indistinguishable in three groups and statistically not signi®cant. The results summarized in Table 2 and Figure 3 . Experimental hyperprolactinemia in a rat model J Rehman et al
Serum prolactin and testosterone
Serum prolactin level in all experimental rats (Group 1) were b 500 ngaml. The rat receiving exogenous testosterone had serum testosterone b 20 times higher than the rats not receiving testosterone.
Discussion
Hyperprolactinemia can be found in about 1 ± 6% of men with impotence. 4, 19 Although rare, it remains a remediable cause of impotence. 20 ± 23 Unlike other anterior pituitary hormones, the dominant regulation of prolactin secretion in man is inhibitory, mediated by hypothalamic dopamine originating in the tuberoinfundibular neurons of the arcuate nucleus. 24, 25 Hyperprolactinemia ensues if for any reason hypothalamic dopamine fails to reach the pituitary lactotroph and bind to the lactotroph membrane receptor, where it acts to suppress both cAMP generation and the phosphoinositide pathways. 26 Additionally it has been suggested that g-aminobutyric acid (GABA) may play a role as inhibitor. Hyperprolactinemia may have effect by inhibiting dopaminergic 27 or dopamine turnover in the MPOA. 28 Hypothalamic disturbances with destruction of dopaminergic neurons, stalk lesions with impaired dopamine transport, and compression of portal vessels by a pituitary tumor 29 impairing the delivery of dopamine are all associated with hyperprolactinemia. 30 ± 32 Medication can cause the hyperprolactinemia by depleting central dopamine stores or blocking dopamine receptors. 33 ± 36 Hyperprolactinemia and coitalasexual dysfunction
Hyperprolactinemia usually is associated with coital dysfunction in men. Both decreased libido and potency have been reported; however it is currently unclear which of the de®cit is predominant. 4, 32, 37 Several studies have suggested that in hyperoprolactinemia libido is primarily affected and impotence is secondary to decreased desire. In another study nocturnal penile tumescence (NPT) was reduced in hyperprolactinemia men in both terms of reduced maximum circumference change and decreased tumescence time. 38, 39 Thus, despite the Previous studies by rendering rats hyperprolactinemia with pituitary grafts under the renal capsule suggests that all measured parameters are reduced. Libido or sexual arousal and is measured in terms of mount and intromission latencies. However these measures are confounded by the erectile processes potency' necessary for the successful execution of copulatory patterns. That could be in the brain, spinal cord or peripheral nerves involved in penile erection. It has been suggested, on pharmacological evidence, that the impotence in hyperprolactinemia results from an effect of prolactin on the central dopaminergic control of erection. 4 Aoki and associates 8 have reported that acute infusion of prolactin into the corporal bodies of dogs inhibited relaxation of corporal smooth muscle subsequently subjected to electrical pulse stimulation of the pelvic nerves. They suggested a direct effect on the smooth muscle function of the cavernous bodies by prolactin. Recent studies also show that the effect of As shown, the rat is anaesthetized and lying supine. The arterial line in the left carotid artery is connected to a MacLab data acquisition board via a transducer and transducer ampli®er, for continuous monitoring of blood pressure. A right external jugular venous line is utilized for intravenous¯uid transfusion or blood sampling. As shown, the prostate has been exposed by a lower midline incision. The cavernous nerves are seen on the posterolateral surface of the prostate arising from the pelvic ganglion that is formed by the joining of the hypogastric and pelvic nerves. The two corpora have been exposed by inguinoscrotal incisions on both sides, combined with degloving of the penis. A line is inserted into the right corpora for continuous monitoring of intracorporal pressure via the Mac Lab instrumentation. Yet another line is inserted in the left corpora for intracavernous drug injection. Lastly, the nerve stimulator probe is placed around the cavernous for current stimulation. Papaverine was injected into the corpus cavernosum using a 23-G needle attached to a syringe. Four bolus injections of papaverine were administered to each rat at half-log increments ranging from 100 ± 3000 mg (i.e. 100 mg, 300 mg, 1000 mg, 3000 mg). The change in intracorporal pressure was monitored with each dose, and all pressure responses were allowed to return to baseline before injection of the subsequent dose % 15 ± 30 min. Changes in intracavernous pressure recorded were plotted as a fractional change in corporal pressure in relation to BP (to standardise) at each dose concentration. Each point on each curve represents the mean AE SE of the fractional change in pressure.
Experimental hyperprolactinemia in a rat model J Rehman et al hyperprolactinemia cannot be attributed to change in serum testosterone. This study shows that hyperprolactinemia affects erectile function independently of other parameters. After induction of hyperprolactinemia re¯exes measured on day 5, 6 and 7 were markedly diminished. Although hyperprolactinemic rats received intramuscular serum testosterone and their serum testosterone was higher than control ( b 206). When these re¯exes were tested by cavernous nerve stimulation they were normal and there was no statistical difference to pressure rise at any level of nerve stimulation (0.5 ± 10 mA).
Duration of induction hyperprolactinemia and onset of coitalaerectile dysfunction
It has been suggested that short-term exposure ( 5 d) to elevated prolactin levels has been shown to enhance sexual arousal by decreasing mount and intromission latencies. 42 However long-term exposure has been found to depress both sexual arousal and potency of men 41, 43, 44 as well as male rats. 1,45 ± 47 Sexual motivation was also inhibited in hyperprolactinemia animals mounting rates after penile anesthetization were signi®cantly reduced, although this effect ®rst appeared 21 days after pituitary transplantation (as compared with the effects in erectile responses noted in these animals 7 d after transplantation). 47 Thus, the results suggest thus de®cits in sexual motivation may be secondary to a de®ciency in erectile function.
This study shows that even the administration of prolactin for short period of time is also associated with coitalaerectile dysfunction. This may be the previous studies have been done by pituitary tumor graft and it takes days to weeks to vascularization of tumor and prolactin level to rise (normal 20 ngaml). The quick onset of erectile dysfunction in our study is as were directly injecting rat prolactin subcutaneously. The rat made hyperprolactinemia by this way had serum prolactin ! 500 ngaml. Abolition of awake penile re¯exes (central) in supine position and preservation of peripheral re¯exes by cavernous nerve stimulation (peripheral) as well as normal response to intracorporal papaverine (corporal smooth muscle) suggest a central effect of hyperprolactinemia.
Hyperprolactinemia and hypogonadism in man
The relationship between prolactin and gonadotropins is complex. 38, 48 In the rat, hyperprolactinemia causes increase in tuberoinfundibular dopamine content, leading to disruption of the normal pulsatility of GnRH and hence LH and FSH secretion. 49 ± 52 Similar mechanisms are believed to operate in the hyperprolactinemia (increased hypothalamic dopamine content) in men leading to inhibition of LH and FSH release. Serum LH is inappropriately low in men with hyperprolactinemia and testosterone de®ciency, suggesting that the hypothalamic ± pituitary axis fails to respond appropriately to reduced testosterone levels. The suggestion implicit in this ®nding is that hyperprolactinemia in some way acts centrally to depress the mechanisms responsible for libido and potency. But Genazzani and associates have shown that the duration of prolactin burst from the pituitary is independent from both prolactin and gonadal steroidal hormones. 53 As the LH and FSH response to exogenous GnRH is frequently normal or frankly excessive in these patients suggesting a normal pituitary gonadotrophin reserve, the defect is likely to reside in the hypothalamus and is generally thought to be a functional and potentially reversible alteration in GnRH secretion. 54 Severe hyperprolactinemia (prolactin b 2000 mUal) may cause hypogonadism and is almost invariably associated with sexual dysfunction in the male.
In this study we did not determine the plasma FSH or LH but as the serum testosterone given to hyperprolactinemia rats. As the nerve induced erection and corporal smooth muscle reactivity to papaverine is normal, it is conceivable that no hypogonadism has no major effect on erectile tissue as well as erectile mechanisms.
Hyperprolactinemia and serum testosterone
Diminished testosterone levels in themselves appear to be rather less important in the mechanism of sexual dysfunction than hyperprolactinemia per se. Experimental hyperprolactinemia in a rat model J Rehman et al Our clinical experience tells us that increasing plasma testosterone by intramuscular injections does not appear to improve potency consistently in hyperprolactinemia patients. In contrast, administration of the dopamine agonist bromocriptine which rapidly lowers prolactin, produces a rapid improvement in potency even when the testosterone level remains subnormal. 55 ± 59 Several abnormalities of testosterone metabolism have been demonstrated in hyperprolactinemia. A direct effect of prolactin on the gonad was suggested studies demonstrating a blunted testosterone response to exogenous human chorionic gonadotrophin (HCG) in hyperprolactinemia. 60 Martikainen and Vinko 61 found a blunted response of plasma 17b-oestradiol to HCG stimulation in hyperprolactinemia, suggesting an inhibition of testicular aromatase activity. Magrini et al 62 failed to demonstrate an alteration in testosterone response to HCG, but found a diminished rise in the testosterone metabolite 5-a dihydrotestosterone, suggesting an inhibitory effect of hyperprolactinemia on 5a-reductase activity in peripheral tissues. In general, therefore, it seems likely that the hypogonadism of hyperprolactinemia is both central and peripheral in origin.
In this study serum testosterone replacement had no effect on recovery of coital ability. That hyperprolactinemia suppresses male rat erectile responses without affecting serum testosterone levels suggests that the deleterious effects of hyperprolactinemia on sexual behavior are not the result of altered testicular function. Similarly, increased adrenocortical activation has been ruled out as a contributing factor. 63 
Hyperprolactinemia and penile re¯exes
Erectile potency can be measured by penile re¯ex tests in the rat. 64 Penile erection can be evoked from rats restrained in a supine position by retracting the prenuptial sheath and maintaining the sheath in a retracted position. 64 The relationship between the responses observed in the supine test and those occurring during copulatory behavior have been described. 65 Penile re¯exes are classi®ed as arising from re¯exogenic (peripheral) or psychogenic (cerebral or supraspinal) causes. Previously hyperprolactinemia rats with transected spinal cord 47 were used to answer these questions but spinal transection involves degeneration of many neurons invalid in other local controls, so the model system has to be intact before these results are accepted on scienti®c grounds. In as much as the inhibitory effects of hyperprolactinemia on sexual arousal and erectile function develop over different time frames, it appears that hyperprolactinemia may be affecting each of these components of sexual activity through separate mechanisms.
Nocturnal penile tumescence in humans is more sensitive to androgens than visual sexual stimuli. However some of the differences may arise from the relative erectogenic strength of the stimuli, rather than from qualitative differences in androgen sensitivity. Erection supporting that during hyperprolactinemia each of the components of male sexual function is inhibited through the separate mechanism.
In our study we have demonstrated that prolactin centrally as hyperprolactinemia has total abolition of penile re¯exes while the re¯exes are unchanged in control rats whether they are given testosterone or not, while nerve stimulated peripheral erection and corporal smooth muscle are normal.
Conclusion and summary
The present experiments were performed to induce hyperprolactinemia in adult male rats to identify whether a central or peripheral mechanism was responsible for the effects of erectile dysfunction. The use of penile re¯exes in awake animals was used to test the effect of both central and peripheral mechanisms. Electrical stimulation of the cavernous nervous was used to test peripheral neural and cavernous nerve function and intracorporal injection of papaverine used to test the intactness of the corporal smooth muscles. This approach allowed a more clear separation of central and peripheral mechanism of erection.
Taken together these data suggest a central neural effect of hyperprolactinemia on erectile function. Hypogonadism does not seem to contribute to the impaired penile re¯exes as documented by replacement of testosterone did not recover the centrally mediated penile re¯exes. These observations may have important implications for the understanding, diagnosis and treatment of hyperprolactinemia patients.
